The potential role of SIRT6 in regulating the crosstalk between Nrf2 and NF-κB pathways in cardiovascular diseases

被引：4
作者：
Casper, Eman [1 ]
机构：
[1] Ain Shams Univ, Dept Clin Pharm, Fac Pharm, Cairo, Egypt
来源：
PHARMACOLOGICAL RESEARCH | 2022年 / 182卷
关键词：
SIRT6; NF-kb; NRF2; Cardiovascular diseases;
D O I：
10.1016/j.phrs.2022.106300
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 3 条
[1]   Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism [J].
Tan, Ying ;
Wan, Hong-hong ;
Sun, Ming-ming ;
Zhang, Wen-jing ;
Dong, Maolong ;
Ge, Wei ;
Ren, Jun ;
Peng, Hu .
ACTA PHARMACOLOGICA SINICA, 2021, 42 (03) :404-413
[2]   Sirtuin 6: A potential therapeutic target for cardiovascular diseases [J].
Xie Saiyang ;
Deng Wei ;
Tang Qizhu .
PHARMACOLOGICAL RESEARCH, 2021, 163
[3]   Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts [J].
Zhang, Qian ;
Tu, Wei ;
Tian, Kunming ;
Han, Lianyong ;
Wang, Qin ;
Chen, Panpan ;
Zhou, Xue .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (01) :93-104
1